Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

JULY 27, 2022

As a Schedule I substance under the Controlled Substances Act, marijuana has a high potential for abuse and no currently accepted medical use in treatment in the United States and lacks accepted safety for use under medical supervision. Food and Drug Administration (FDA) has federal authority to approve drugs for medicinal use in the U.S.

Marijuana 52

Marijuana DEA State Laws Policy 52

Cannabis Law Report

AUGUST 5, 2021

Regulatory authority would move from the DEA to the FDA, but also the ATF and the Alcohol and Tobacco Tax and Trade Bureau (TTB). There will also be a role for the Treasury and the Consumer Product Safety Commission. Jimmy McMillan became somewhat infamous as a NYC Mayoral candidate in 2005 and 2009 (he also ran for Governor in 2018).

Banking 111

Banking Vaping Education DEA 111